GCT at National Alzheimer’s Summit

GCT President, Dr. Jeffrey Apter, is attending The National Alzheimer’s Summit this week.

Started September 24, summit will continue for three engaging days bringing together the very best minds in Alzheimer’s and dementia research network. The summit highlights community efforts to identify common goals, link partners, and unite in the fight against Alzheimer’s.

The most critical trends that are being discussed are patient-centered research and drug development, racial and ethnic disparities, the mobilization of young people, biomarker development to speed the diagnosis of Alzheimer’s, and the power of brain health to transform the ways families and communities talk about Alzheimer’s. The participants are striving to control and effectively treat the disease by 2025.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.